false
OasisLMS
Login
Catalog
SHM Converge Scientific Abstract ePoster Gallery
There's a Fungus Among Us: A Case of Mucormycosis ...
There's a Fungus Among Us: A Case of Mucormycosis in the Setting of Calciphylaxis
Back to course
Pdf Summary
This case describes a rare and severe episode of cutaneous mucormycosis occurring in a calciphylaxis wound. A 41-year-old man with type 1 diabetes, end-stage renal disease on hemodialysis, calciphylaxis, and anemia presented with worsening pain, malodor, and bleeding from a left thigh lesion. Exam showed a large unroofed blister with surrounding necrotic-appearing dark skin, and he was febrile, tachycardic, and mildly tachypneic. CT of the thigh demonstrated soft tissue gas concerning for necrotizing fasciitis.<br /><br />He underwent emergent surgical debridement and wound vacuum placement, and broad-spectrum antibiotics were started. Initial bacterial cultures grew Staphylococcus epidermidis and Clostridium perfringens, while fungal and mycobacterial cultures were initially negative. Several weeks later, histopathology from an enlarging adjacent lesion identified Rhizopus species, confirming mucormycosis despite earlier negative cultures. He required additional debridements and was treated with liposomal amphotericin B, with posaconazole added later.<br /><br />The patient subsequently developed right eye swelling, and imaging revealed a left upper lobe cavitary lung lesion. Bronchoscopy and fungal studies remained negative, but his course continued to worsen with an Enterobacter empyema and progressive decline. He ultimately transitioned to comfort care and died, with suspected progression from localized cutaneous disease to systemic infection.<br /><br />This report highlights that mucormycosis is a rare, high-mortality fungal infection most often caused by Rhizopus, Mucor, Lichtheimia, and Rhizomucor species. Major risk factors include diabetes, immunosuppression, trauma, and other states of impaired host defense. In this patient, diabetes plus skin breakdown from calciphylaxis likely created a high-risk portal of entry. Diagnosis is often difficult because cultures may be negative, making histopathology essential. Optimal management requires prompt surgical debridement plus antifungal therapy, typically liposomal amphotericin B and posaconazole.
Asset Subtitle
Mary-Nel Saarloos
Meta Tag
Author List
Jennifer M. Chang-Wolf, Mary-Nel Saarloos
Category
Clinical Vignettes
Concept
Cutaneous Mucormycosis
Concept
Mucormycosis
Concept
Surgical Debridement
Concept
Liposomal Amphotericin B
Concept
Calciphylaxis
Distinguished
Non-Finalist
Presenter Organization
Duke University Hospital
Presenting Author
Mary-Nel Saarloos
Track
Adult
Keywords
cutaneous mucormycosis
calciphylaxis
Rhizopus
type 1 diabetes
end-stage renal disease
hemodialysis
necrotizing fasciitis
liposomal amphotericin B
posaconazole
surgical debridement
Cutaneous Mucormycosis
Mucormycosis
Surgical Debridement
Liposomal Amphotericin B
Calciphylaxis
×
Please select your language
1
English